Santa Rosa, CA, United States of America

Martin Terry Rothman

This inventor holds 48 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Neuromodulation Devices. Top assignees: Limflow Gmbh, Corflow Therapeutics Ag, Intravascular Research Limited. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Terry Rothman. Retrieved from https://idiyas.com/inventor/martin-terry-rothman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 48 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.1

ph-index = 18

Forward Citations = 1,097(Granted Patents)


Location History:

  • London, GB (1992 - 2001)
  • Bodega Bay, CA (US) (2022 - 2023)
  • Santa Rosa, CA (US) (2015 - 2024)

Company Filing History:


Years Active: 1992-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neuromodulation
Mechanical Circulatory Support
Fluid Flow Management
Renal Nerve Modulation
Microvascular Dysfunction
Transcatheter Valve Replacement
Minimally Invasive Surgery
Stent-Graft Placement
Centrifugal Impeller
Cardio-Renal Syndrome
Intracoronary Characterization
Short Term Support
48 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Martin Terry Rothman

Introduction

Martin Terry Rothman, based in Santa Rosa, CA, is a prominent inventor with an impressive portfolio of 39 patents. His work primarily focuses on innovations in the medical field, particularly related to cardiovascular health and mechanical circulatory support devices. Rothman's inventions are characterized by their practical applications and potential to significantly improve patient outcomes.

Latest Patents

Among Rothman's latest patents is a system and methods for treating Microvascular Obstruction (MVO). This innovative approach allows for the introduction of an injectate into affected blood vessels at precise flow rates while blocking retrograde flow. By leveraging the natural pumping of the heart, this technique effectively pushes the injectate into compromised microvessels. Additionally, Rothman has developed a mechanical circulatory support device featuring a centrifugal impeller designed for implantation in the descending aorta. This device operates in conjunction with the native heart, utilizing a centrifugal pump, and optimizes blood flow while potentially replicating the natural vortex formation in the aorta. The design includes multiple enhancements to improve pressure efficiency and flow rate, showcasing Rothman's commitment to advancing medical technology.

Career Highlights

Throughout his career, Martin Terry Rothman has worked with leading companies such as Limflow GmbH and Corflow Therapeutics AG. His contributions in these organizations have further established him as a respected figure in the field of medical inventions. His innovative solutions and dedication to research have propelled advancements in life-saving technologies.

Collaborations

Rothman has collaborated with esteemed professionals in the industry, including colleagues Robert Julian Dickinson and Andrew Robert Pacey. Their teamwork has fostered an environment of innovation and creativity, leading to the development of groundbreaking medical devices. These collaborations highlight the importance of joint efforts in the field of inventiveness and technology.

Conclusion

Martin Terry Rothman's contributions to medical technology through his numerous patents demonstrate his expertise and innovative spirit. His work continues to have a profound impact on cardiovascular treatments and mechanical support systems, making a significant difference in the lives of patients. As he pushes the boundaries of conventional medicine, Rothman exemplifies the role of a modern inventor, dedicated to improving health outcomes through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…